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GASTROINTESTINAL DISORDERS—
Methods & Concepts
PGI14
ONE WEEK VERSUS DAILY RECALL OF SYMPTOMS OF
INFANT GERD: DOES IT MAKE A DIFFERENCE?
Zhang H1, Rothman M2, Xiao X3, Frustaci ME3, Mulberg A3
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OBJECTIVES: Conﬂicting evidence exists regarding whether
very short recall periods are required for making valid judgments
about the effectiveness of health care interventions. This analy-
sis explored the inﬂuence of two factors thought to impact recall,
recency and signiﬁcance of events, on caregiver recall of symp-
toms of infant gastroesophageal reﬂux disease (GERD).
METHODS: Retrospective analyses were conducted on 185
infants with GERD from a multi-national validation study of 
the Revised Infant-Gastroesophageal Reﬂux Questionnaire (I-
GERG-R), a measure of symptom severity. Primary caregivers
completed a 12-item I-GERQ-R weekly and a 5-item diary daily
during the three-week study period. Due to word limitations, this
abstract only reports results from the ‘frequency of spit-up’ item
during the ﬁrst week. RESULTS: Overall, a moderately high
Pearson correlation (r = 0.636) was observed between the diary
and the I-GERQ-R item. When the open-ended diary responses
were recoded into the same structured format as the I-GERQ-R
item, the correlation improved signiﬁcantly (r = 0.829), indicat-
ing that initial moderate correlation was largely due to the dif-
ferent response format rather than recall bias. The correlations
between the I-GERQ-R item and the average of the diary item
were about equal between the last two days and the ﬁrst two
days of the ﬁrst week (original: r = 0.585 and 0.589; recoded: r
= 0.758 and 0.745), indicating that the I-GERQ-R response was
not largely inﬂuenced by the most recent 2-day experience. The
correlations between the I-GERQ-R item and the diary item on
the day with the largest number of reported spit-ups were not
larger than that between I-GERQ-R and the average diary score
of other 6 days (original: r = 0.627 and 0.630; recoded: 0.767
and 0.821), indicating that I-GERQ-R was not largely inﬂuenced
by the most symptomatic day. CONCLUSION: Overall, we
found that recency and high frequency of the event did not
unduly inﬂuence parent’s recall of infant GERD symptoms.
GASTROINTESTINAL DISORDERS—
Patient-Reported Outcomes
PGI15
MENTAL AND PHYSICAL FUNCTIONING REDUCED AMONG
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OBJECTIVES: Assess health-related quality of life (HRQOL)
among patients with gastroesophageal reﬂux disease (GERD)
who have frequent symptoms considered atypical for GERD.
METHODS: A sample of US adults participated in a web survey
including the GERD Symptom & Medication Questionnaire
(GERD-SMQ), a validated GERD screener. Frequency of atypi-
cal symptoms (globus, sinusitis, dry coughing, throat clearing,
sore throat, snoring, wheezing, choking, non-cardiac chest pain,
and hoarseness) during the previous 3 months were assessed. Fre-
quent symptoms were deﬁned as ≥ 2 days/nights per week with
each symptom. SF-36 Mental Component Summary (MCS) and
Physical Component Summary (PCS) scores were calculated and
mean differences were compared for respondents with GERD
and atypical symptoms vs. those with GERD but without atypi-
cal symptoms. Bonferroni correction was used to adjust for mul-
tiple comparisons testing. Lower scores signiﬁed worse HRQOL;
differences of 2 or more points are generally considered clinically
signiﬁcant. RESULTS: A total of 2805 of 18,213 invited to par-
ticipate responded. 2603 satisﬁed the study criteria; 701 were
individuals with GERD. Overall, 74% and 66% of individuals
with GERD reported at least one nighttime or daytime atypical
symptom, respectively. Mean MCS and PCS scores among
GERD cases were signiﬁcantly lower among those with vs.
without each nighttime atypical symptom (P < 0.007 for all
nighttime atypical symptoms). Similar reductions in mean MCS
and PCS were seen among GERD cases with daytime atypical
symptoms when compared to those without each daytime
symptom (P < 0.0056 for all). Mean MCS and PCS scores were
4–10 points lower among GERD cases with atypical symptoms
compared with GERD cases without atypical symptoms. CON-
CLUSION: Nighttime and daytime atypical symptoms were
associated with signiﬁcantly lower HRQOL scores. Among
GERD patients, there may be an incremental negative impact of
atypical symptoms on mental and physical functioning. Clini-
cians should determine the presence of atypical symptoms in an
effort to improve HRQOL in patients with GERD.
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OBJECTIVES: The decision to perform cholecystectomy in case
of gallstones is based on a trade-off between the costs and risks
of treatment related complications at the one hand and the mor-
tality and morbidity associated with gallstones on the other
hand. An adequate instrument for treatment planning, outcome
monitoring, and clinical trials of patients with gallstone-related
symptoms is therefore crucial. The Gastrointestinal Quality of
Life Index (GIQLI) questionnaire has previously been validated
for various gastrointestinal disorders. The purpose of the present
study was to validate the Swedish translation of GIQLI speciﬁ-
cally for gallstone disease. METHODS: GIQLI was translated to
Swedish and re-translated back to German for linguistic control.
Responsiveness was tested in 187 consecutive patients who
underwent planned cholecystectomy. Internal consistency and
test-retest stability 12 and 15 months after surgery was tested on
the same sample. Construct validity was assessed by comparing
the GIQLI score with the bodily pain scale of SF-36 and four
single-item questions regarding pain frequency, pain localisation,
the patient’s own conviction of the origin of pain, and a VAS-
scale in x consecutive patients. RESULTS: No major deviation
was found between the original questionnaire and the re-
translated version. A high responsiveness was seen, with GIQLI
score increasing from 95.1 (SD 24.8) to 111.8 (SD 20.1) six
months after surgery (p < 0.001). The GIQLI score correlated
signiﬁcantly with all other measures of gallstone-related symp-
toms except a question regarding the patient’s own conviction of
the origin of the symptoms. There was a high test-retest stabil-
A152 Abstracts
ity, with signiﬁcant correlations between the ratings 12 and 15
months for all items except one. Cronbach’s alpha was found to
be 0.91. CONCLUSION: The Swedish translation of GIQLI has
a high validity and reliability for assessing gallstone-related
symptoms.
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US COHORT
Wahlqvist P1, Karlsson M1, Johnson D2, Carlsson J1, Bolge SC3,
Wallander MA1
1AstraZeneca R&D, Mölndal, Sweden, 2Eastern Virginia Medical
School, Norfolk,VA, USA, 3Consumer Health Sciences, Princeton, NJ,
USA
OBJECTIVES: To describe the relationship between symptoms
of gastroesophageal reﬂux disease (GERD) and self-reported
concomitant diseases, health-related quality of life and work pro-
ductivity. METHODS: An exploratory database analysis was
performed on results from the 2004 National Health and Well-
ness Survey. US respondents with self-reported symptoms of
GERD (n = 10,028, mean age: 52 years, 58% female) were age-
and sex-matched to controls without GERD symptoms (n =
10,028). Information on health-related quality of life was
obtained using the Short-Form (SF)-8 questionnaire. Data on
health-related reduced productivity while at work or when per-
forming daily activities were obtained using the generic version
of the Work Productivity and Activity Impairment questionnaire.
Respondents with GERD were classiﬁed by self-reported
symptom severity (mild, moderate or severe) and frequency (low
or medium-to-high: symptoms on <2 days or ≥2 days per week,
respectively). RESULTS: Respondents with GERD had the fol-
lowing distribution with regard to symptom severity and fre-
quency: 52% had mild and low; 12% mild and medium-to-high;
10% moderate and low; 18% moderate and medium-to-high;
2% severe and low; 6% severe and medium-to-high. Compared
with controls, respondents with GERD symptoms had a larger
number of concomitant diseases (mean difference [MD]: 1.6),
lower SF-8 physical and mental health scores (MD: 4.1 and 3.1
units, respectively), more absence from work (MD: 0.9 hours per
week), and a higher percentage of health-related reduced pro-
ductivity while at work (MD: 7.5% units) and when performing
daily activities (MD: 12.1% units). The difference between the
control group and respondents with GERD increased with
increasing symptom severity and/or frequency for all variables.
CONCLUSION: Increasing severity and frequency of GERD
symptoms is associated with more concomitant diseases, lower
health-related quality of life, and reduced work productivity.
Further studies are needed to help identify patient populations
in which re-evaluating the management of GERD may be 
warranted.
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OBJECTIVES: To evaluate the impact of gastroesophageal reﬂux
disease (GERD) on health-related quality of life (HRQoL) of
affected individuals in Shanghai. METHODS: A representative
sample of 1200 adults was selected using a randomized cluster
sampling method. Subjects completed mainland Chinese versions
of the Reﬂux Disease Questionnaire (RDQ), GERD Impact Scale
(GIS), Quality of Life in Reﬂux and Dyspepsia questionnaire
(QOLRAD) and Short Form-36 (SF-36). A clinically meaningful
impairment of HRQoL was deﬁned as a statistically signiﬁcant
decrease of ≥ 0.5 points in a 7-point QOLRAD domain or ≥ 5
points in a 100-point SF-36 domain. RESULTS: 1034 subjects
completed the survey (response rate: 86.2%); 919 responses were
suitable for analysis (mean age: 46.7 years; 55.4% female). Sub-
jects with GERD (n = 57) had meaningfully impaired HRQoL
compared with subjects without GERD (n = 862) in terms 
of impaired vitality (mean QOLRAD scores: 6.34 vs 7.00),
food/drink problems (6.39 vs 7.00) and emotional distress (6.46
vs 7.00) (all ≤ 0.001), but not sleep disturbance (6.54 vs 7.00)
and impaired physical/social functioning (6.67 vs 7.00) (both P
≤ 0.001); and in the SF-36 dimensions of role-physical (mean SF-
36 scores: 71.9 vs 95.2), general health (49.2 vs 70.1), role-
emotional (76.6 vs 96.4), bodily pain (76.3 vs 95.8), vitality
(54.9 vs 72.9), mental health (71.9 vs 82.4) and physical func-
tion (81.4 vs 90.3) (all P < 0.001) but not social function (90.6
vs 94.5, P = 0.02). According to the GIS, the most common prob-
lems caused by GERD were interference with eating and drink-
ing (4.1% of the study population), sleep impairment (2.5%) and
reduced work productivity (2.5%). CONCLUSION: GERD has
a clinically meaningful impact on the HRQoL of affected indi-
viduals in the general population of Shanghai. Further research
is needed to assess how this effect responds to appropriate acid-
suppressive therapy.
HEMATOLOGICAL DISEASES—
Clinical Outcomes Studies
PHM1
A COMPARISON OF INPATIENT OUTCOMES BETWEEN
SICKLE CELL DISEASE AND NON-SICKLE CELL DISEASE
PATIENTS UNDERGOING HIGH-VOLUME SURGICAL
PROCEDURES
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OBJECTIVES: To examine differences in length of stay and inpa-
tient mortality between hospitalizations for patients with sickle
cell disease (SCD) versus patients without SCD undergoing high-
volume surgical procedures. METHODS: We analyzed data
from the 2004 Nationwide Inpatient Sample (NIS) from the
Health care Cost and Utilization Project. Clinical Classiﬁcation
Software (CCS) codes were used to identify discharges for
patients who underwent one of six surgical procedures: (CCS 45)
percutaneous transluminal coronary angioplasty (PTCA), (CCS
80) appendectomy, (CCS 84) cholecystectomy, (CCS 124) hys-
terectomy, (CCS 152) arthroplastic knee surgery, and (CCS 153)
hip replacement. CCS code 61 was used to identify patients with
SCD. National estimates were computed using weights provided
in the NIS, and unadjusted comparisons of demographic and
outcome variables between SCD and non-SCD were performed
using chi-square and t-tests as appropriate. To adjust for corre-
lations within hospitals, generalized estimating equations were
used to compare length of stay (LOS) and inpatient mortality
controlling for age and comorbidities. RESULTS: SCD patients
undergoing all six surgical procedures were signiﬁcantly younger
than non-SCD patients. In unadjusted analyses, inpatient LOS
was longer in SCD vs. non-SCD patients (PTCA: 2.9 vs. 2.8 days;
appendectomy: 5.5 vs. 2.9; cholecystectomy: 6.3 vs. 4.7; hys-
terectomy: 3.4 vs. 2.7; knee arthroplasty: 5.4 vs. 3.9 and hip
